Longtime GC of Biotech That Discovered Leading Hep-C Cure Announces Retirement
Nathaniel Gardiner will retire at the end of March 2024, after 28 years with Entata Pharmaceuticals.
Nathaniel Gardiner will retire at the end of March 2024, after 28 years with Entata Pharmaceuticals.